Bayer has warned that Europeans will have to pay more for medicines if the region is to remain an attractive market for new ...
The company is looking at expanding its manufacturing footprint in the U.S., the head of its pharma unit said, turning to the ...
Many large-cap pharma stocks traded higher Wednesday after Johnson & Johnson (NYSE:JNJ), the industry bellwether in the earnings season, posted better-than-expected Q2 2024 financials, thanks mainly ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Teva, which continues on track with its corporate revamp initiated a year ago, named pharma veteran Matthew Shields as executive vice president of its global operations division responsible for ...
ZURICH, Jan 14 (Reuters) - Bayer (BAYGn.DE), opens new tab will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the German company's ...
Roche Holding is narrowing the diseases it targets with its pharmaceutical research and development activities, betting on a slimmed-down approach as it pushes into the market for weight-loss drugs.
PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services, and the pharmaceutical division of ...
Shionogi & Co. said it plans to acquire Japan Tobacco Inc. (JT) subsidiaries Torii Pharmaceutical Co. and Akros Pharma Inc. for ¥160 billion (US$1.1 billion) to expand its global R&D business. The ...
Natco Pharma’s board approved the demerger of its agrochemicals business into wholly owned subsidiary Natco Crop Health ...
Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — Alcon’s U.S. pharmaceutical division shared its focus on glaucoma and dry eye with attendees ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results